Drug Profile
Research programme: anabolic musculoskeletal therapeutics - Vibe Pharmaceuticals
Alternative Names: VB-102Latest Information Update: 28 Jan 2020
Price :
$50
*
At a glance
- Originator University of Pennsylvania
- Developer Vibe Pharmaceuticals
- Class Proteins
- Mechanism of Action Bone development stimulants; Osteogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Osteoporosis; Sarcopenia
Most Recent Events
- 28 Jan 2020 No recent reports of development identified for preclinical development in Osteoporosis in USA
- 28 Jan 2020 No recent reports of development identified for preclinical development in Sarcopenia in USA